Deficiency of TNFR1 protects myocardium through SOCS3 and IL-6 but not p38 MAPK or IL-1β

Meijing Wang, Troy Markel, Paul Crisostomo, Christine Herring, Kirstan K. Meldrum, Keith D. Lillemoe, Daniel R. Meldrum

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Tumor necrosis factor-α (TNF-α) plays an important role in the development of heart failure. There is a direct correlation between myocardial function and myocardial TNF levels in humans. TNF may induce local inflammation to exert tissue injury. On the other hand, suppressors of cytokine signaling (SOCS) proteins have been shown to inhibit proinflammatory signaling. However, it is unknown whether TNF mediates myocardial inflammation via STAT3/SOCS3 signaling in the heart and, if so, whether this effect is through the type 1 55-kDa TNF receptor (TNFR1). We hypothesized that TNFR1 deficiency protects myocardial function and decreases myocardial IL-6 production via the STAT3/SOCS3 pathway in response to TNF. Isolated male mouse hearts (n = 4/group) from wild-type (WT) and TNFR1 knockout (TNFR1KO) were subjected to direct TNF infusion (500 pg·ml-1·min-1 × 30 min) while left ventricular developed pressure and maximal positive and negative values of the first derivative of pressure were continuously recorded. Heart tissue was analyzed for active forms of STAT3, p38, SOCS3 and SOCS1 (Western blot analysis), as well as IL-1β and IL-6 (ELISA). Coronary effluent was analyzed for lactate dehydrogenase (LDH) activity. As a result, TNFR1KO had significantly better myocardial function, less myocardial LDH release, and greater expression of SOCS3 (percentage of SOCS3/GAPDH: 45 ±- 4.5% vs. WT 22 ±- 6.5%) after TNF infusion. TNFR1 deficiency decreased STAT3 activation (percentage of phospho-STAT3/STAT3: 29 -± 6.4% vs. WT 45 ±- 8.8%). IL-6 was decreased in TNFR1KO (150.2 ±- 3.65 pg/mg protein) versus WT (211.4 -± 26.08) mice. TNFR1 deficiency did not change expression of p38 and IL-1β following TNF infusion. These results suggest that deficiency of TNFR1 protects myocardium through SOCS3 and IL-6 but not p38 MAPK or IL-1β.

Original languageEnglish
JournalAmerican Journal of Physiology - Heart and Circulatory Physiology
Volume292
Issue number4
DOIs
StatePublished - Apr 2007

Fingerprint

Receptors, Tumor Necrosis Factor, Type I
p38 Mitogen-Activated Protein Kinases
Interleukin-1
Interleukin-6
Myocardium
L-Lactate Dehydrogenase
Suppressor of Cytokine Signaling Proteins
Inflammation
Ventricular Pressure
Heart Failure
Tumor Necrosis Factor-alpha
Western Blotting
Enzyme-Linked Immunosorbent Assay
Pressure

Keywords

  • Cytokines
  • Inflammation
  • Ischemia
  • Reperfusion
  • Signaling
  • Suppressors of cytokine signaling
  • Tumor necrosis factor receptor type 1

ASJC Scopus subject areas

  • Physiology

Cite this

Deficiency of TNFR1 protects myocardium through SOCS3 and IL-6 but not p38 MAPK or IL-1β. / Wang, Meijing; Markel, Troy; Crisostomo, Paul; Herring, Christine; Meldrum, Kirstan K.; Lillemoe, Keith D.; Meldrum, Daniel R.

In: American Journal of Physiology - Heart and Circulatory Physiology, Vol. 292, No. 4, 04.2007.

Research output: Contribution to journalArticle

Wang, Meijing ; Markel, Troy ; Crisostomo, Paul ; Herring, Christine ; Meldrum, Kirstan K. ; Lillemoe, Keith D. ; Meldrum, Daniel R. / Deficiency of TNFR1 protects myocardium through SOCS3 and IL-6 but not p38 MAPK or IL-1β. In: American Journal of Physiology - Heart and Circulatory Physiology. 2007 ; Vol. 292, No. 4.
@article{653b27d621314ede8a8c270fc9dd3775,
title = "Deficiency of TNFR1 protects myocardium through SOCS3 and IL-6 but not p38 MAPK or IL-1β",
abstract = "Tumor necrosis factor-α (TNF-α) plays an important role in the development of heart failure. There is a direct correlation between myocardial function and myocardial TNF levels in humans. TNF may induce local inflammation to exert tissue injury. On the other hand, suppressors of cytokine signaling (SOCS) proteins have been shown to inhibit proinflammatory signaling. However, it is unknown whether TNF mediates myocardial inflammation via STAT3/SOCS3 signaling in the heart and, if so, whether this effect is through the type 1 55-kDa TNF receptor (TNFR1). We hypothesized that TNFR1 deficiency protects myocardial function and decreases myocardial IL-6 production via the STAT3/SOCS3 pathway in response to TNF. Isolated male mouse hearts (n = 4/group) from wild-type (WT) and TNFR1 knockout (TNFR1KO) were subjected to direct TNF infusion (500 pg·ml-1·min-1 × 30 min) while left ventricular developed pressure and maximal positive and negative values of the first derivative of pressure were continuously recorded. Heart tissue was analyzed for active forms of STAT3, p38, SOCS3 and SOCS1 (Western blot analysis), as well as IL-1β and IL-6 (ELISA). Coronary effluent was analyzed for lactate dehydrogenase (LDH) activity. As a result, TNFR1KO had significantly better myocardial function, less myocardial LDH release, and greater expression of SOCS3 (percentage of SOCS3/GAPDH: 45 ±- 4.5{\%} vs. WT 22 ±- 6.5{\%}) after TNF infusion. TNFR1 deficiency decreased STAT3 activation (percentage of phospho-STAT3/STAT3: 29 -± 6.4{\%} vs. WT 45 ±- 8.8{\%}). IL-6 was decreased in TNFR1KO (150.2 ±- 3.65 pg/mg protein) versus WT (211.4 -± 26.08) mice. TNFR1 deficiency did not change expression of p38 and IL-1β following TNF infusion. These results suggest that deficiency of TNFR1 protects myocardium through SOCS3 and IL-6 but not p38 MAPK or IL-1β.",
keywords = "Cytokines, Inflammation, Ischemia, Reperfusion, Signaling, Suppressors of cytokine signaling, Tumor necrosis factor receptor type 1",
author = "Meijing Wang and Troy Markel and Paul Crisostomo and Christine Herring and Meldrum, {Kirstan K.} and Lillemoe, {Keith D.} and Meldrum, {Daniel R.}",
year = "2007",
month = "4",
doi = "10.1152/ajpheart.01063.2006",
language = "English",
volume = "292",
journal = "American Journal of Physiology",
issn = "0193-1857",
publisher = "American Physiological Society",
number = "4",

}

TY - JOUR

T1 - Deficiency of TNFR1 protects myocardium through SOCS3 and IL-6 but not p38 MAPK or IL-1β

AU - Wang, Meijing

AU - Markel, Troy

AU - Crisostomo, Paul

AU - Herring, Christine

AU - Meldrum, Kirstan K.

AU - Lillemoe, Keith D.

AU - Meldrum, Daniel R.

PY - 2007/4

Y1 - 2007/4

N2 - Tumor necrosis factor-α (TNF-α) plays an important role in the development of heart failure. There is a direct correlation between myocardial function and myocardial TNF levels in humans. TNF may induce local inflammation to exert tissue injury. On the other hand, suppressors of cytokine signaling (SOCS) proteins have been shown to inhibit proinflammatory signaling. However, it is unknown whether TNF mediates myocardial inflammation via STAT3/SOCS3 signaling in the heart and, if so, whether this effect is through the type 1 55-kDa TNF receptor (TNFR1). We hypothesized that TNFR1 deficiency protects myocardial function and decreases myocardial IL-6 production via the STAT3/SOCS3 pathway in response to TNF. Isolated male mouse hearts (n = 4/group) from wild-type (WT) and TNFR1 knockout (TNFR1KO) were subjected to direct TNF infusion (500 pg·ml-1·min-1 × 30 min) while left ventricular developed pressure and maximal positive and negative values of the first derivative of pressure were continuously recorded. Heart tissue was analyzed for active forms of STAT3, p38, SOCS3 and SOCS1 (Western blot analysis), as well as IL-1β and IL-6 (ELISA). Coronary effluent was analyzed for lactate dehydrogenase (LDH) activity. As a result, TNFR1KO had significantly better myocardial function, less myocardial LDH release, and greater expression of SOCS3 (percentage of SOCS3/GAPDH: 45 ±- 4.5% vs. WT 22 ±- 6.5%) after TNF infusion. TNFR1 deficiency decreased STAT3 activation (percentage of phospho-STAT3/STAT3: 29 -± 6.4% vs. WT 45 ±- 8.8%). IL-6 was decreased in TNFR1KO (150.2 ±- 3.65 pg/mg protein) versus WT (211.4 -± 26.08) mice. TNFR1 deficiency did not change expression of p38 and IL-1β following TNF infusion. These results suggest that deficiency of TNFR1 protects myocardium through SOCS3 and IL-6 but not p38 MAPK or IL-1β.

AB - Tumor necrosis factor-α (TNF-α) plays an important role in the development of heart failure. There is a direct correlation between myocardial function and myocardial TNF levels in humans. TNF may induce local inflammation to exert tissue injury. On the other hand, suppressors of cytokine signaling (SOCS) proteins have been shown to inhibit proinflammatory signaling. However, it is unknown whether TNF mediates myocardial inflammation via STAT3/SOCS3 signaling in the heart and, if so, whether this effect is through the type 1 55-kDa TNF receptor (TNFR1). We hypothesized that TNFR1 deficiency protects myocardial function and decreases myocardial IL-6 production via the STAT3/SOCS3 pathway in response to TNF. Isolated male mouse hearts (n = 4/group) from wild-type (WT) and TNFR1 knockout (TNFR1KO) were subjected to direct TNF infusion (500 pg·ml-1·min-1 × 30 min) while left ventricular developed pressure and maximal positive and negative values of the first derivative of pressure were continuously recorded. Heart tissue was analyzed for active forms of STAT3, p38, SOCS3 and SOCS1 (Western blot analysis), as well as IL-1β and IL-6 (ELISA). Coronary effluent was analyzed for lactate dehydrogenase (LDH) activity. As a result, TNFR1KO had significantly better myocardial function, less myocardial LDH release, and greater expression of SOCS3 (percentage of SOCS3/GAPDH: 45 ±- 4.5% vs. WT 22 ±- 6.5%) after TNF infusion. TNFR1 deficiency decreased STAT3 activation (percentage of phospho-STAT3/STAT3: 29 -± 6.4% vs. WT 45 ±- 8.8%). IL-6 was decreased in TNFR1KO (150.2 ±- 3.65 pg/mg protein) versus WT (211.4 -± 26.08) mice. TNFR1 deficiency did not change expression of p38 and IL-1β following TNF infusion. These results suggest that deficiency of TNFR1 protects myocardium through SOCS3 and IL-6 but not p38 MAPK or IL-1β.

KW - Cytokines

KW - Inflammation

KW - Ischemia

KW - Reperfusion

KW - Signaling

KW - Suppressors of cytokine signaling

KW - Tumor necrosis factor receptor type 1

UR - http://www.scopus.com/inward/record.url?scp=34147185577&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34147185577&partnerID=8YFLogxK

U2 - 10.1152/ajpheart.01063.2006

DO - 10.1152/ajpheart.01063.2006

M3 - Article

C2 - 17114246

AN - SCOPUS:34147185577

VL - 292

JO - American Journal of Physiology

JF - American Journal of Physiology

SN - 0193-1857

IS - 4

ER -